Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

Pablo Barreiro(Hospital Clínico San Carlos), Juan González‐Lahoz, Vincent Soriano(Fundación Instituto Valenciano de Oncología), Richard M. W. Hoetelmans(Rafael Advanced Defense Systems (Israel)), Daniel González de Requena(University of Turin), Inmaculada Jiménez‐Nácher(Rafael Advanced Defense Systems (Israel)), María Jesús Téllez(Hospital Clínico San Carlos), Vicente Estrada(Instituto de Salud Carlos III)

AIDS

September 1, 2000

10.1097/00002030-200009290-00012

Cited by 81

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

|JAMA|2016|1.4k

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19

|JAMA|2021|728

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel

|AIDS|2002|443

Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy

|The Journal of Infectious Diseases|2005|385